Daratumumab for treatment-refractory acquired idiopathic pure red cell aplasia
Naseema Gangat +5 more
doaj +1 more source
Immunological features of acquired pure red cell aplasia: Specific human leucocyte antigen alleles, signal transducer and activator of transcription 3 mutations and a unique T-cell receptor beta motif. [PDF]
Yamashita N +11 more
europepmc +1 more source
Ectopic Cervical Thymoma with Myasthenia Gravis and Pure Red Cell Aplasia: A Case Report. [PDF]
Narusawa E +9 more
europepmc +1 more source
Erythrovirus-B19-Induced Pure Red Cell Aplasia Revealing Untreated HIV Infection. [PDF]
Moreno Fonseca P +7 more
europepmc +1 more source
Roxadustat in the Treatment of Pure Red Cell Aplasia Associated With Anti-EPO Antibodies. [PDF]
Serrano B +5 more
europepmc +1 more source
Acquired Pure Red Cell Aplasia Following BNT162b2 mRNA COVID-19 Vaccination. [PDF]
Hayase N +3 more
europepmc +1 more source
Sirolimus plus roxadustat synergistically enhances immunosuppression and erythropoiesis in pure red cell aplasia: a multicenter trial. [PDF]
Wang H +25 more
europepmc +1 more source
Exploring the Origin of Cells in the Progression of Primary Myelofibrosis to Acute Myeloid Leukemia Case Report. [PDF]
Papayanis P +4 more
europepmc +1 more source
Parvovirus B19 infection preceding the diagnosis of childhood myelodysplastic syndrome with low blasts: a case report. [PDF]
Klingel L +5 more
europepmc +1 more source

